...acquisitions and alliances. Its Twinject epinephrine auto-injector is approved for emergency anaphylaxis. Macroflux 10/10/2006 $75.00 Macroflux... ...acquisitions and alliances. Its Twinject epinephrine auto-injector is approved for emergency anaphylaxis. Macroflux 10/10/2006 $75.00 Macroflux...
Macroflux Corp. , Mountain View, Calif. Business: Drug delivery Hired: M. Cory Zwerling as president and CEO, former president of Bristol-Myers Squibb Co. 's Bristol-Myers Squibb Medical Imaging unit; he replaces interim CEO Judy Hemberger
WIR...
Macroflux Corp. , Mountain View, Calif. Business: Drug delivery Appointed: Jim Barrett, general partner at New Enterprise Associates; Mike Raab, a partner at New Enterprise; Justin Duckworth, investment advisor at HBM Partners AG; and Nomura Phase4...
...technology into Macroflux Corp. (Mountain View, Calif.). Alza will retain an undisclosed stake in the newco. Macroflux... ...to enter Phase II testing to treat severe osteoporosis by the first half of 2007. Macroflux... ...COO of Pharmion Corp , is Macroflux’s CEO. Peter Daddona, who was CSO of Alza’s Macroflux...
...Macroflux (Mountain View, Calif.). The newco will develop compounds using its Macroflux transdermal delivery technology. Macroflux... ...The product is expected to enter Phase II testing by the first half of 2007. Macroflux... ...Pharmion (PHRM), is CEO of the newco; and Peter Daddona, who was CSO of Alza's Macroflux...
...acquisitions and alliances. Its Twinject epinephrine auto-injector is approved for emergency anaphylaxis. Macroflux 10/10/2006 $75.00 Macroflux... ...acquisitions and alliances. Its Twinject epinephrine auto-injector is approved for emergency anaphylaxis. Macroflux 10/10/2006 $75.00 Macroflux...
Macroflux Corp. , Mountain View, Calif. Business: Drug delivery Hired: M. Cory Zwerling as president and CEO, former president of Bristol-Myers Squibb Co. 's Bristol-Myers Squibb Medical Imaging unit; he replaces interim CEO Judy Hemberger
WIR...
Macroflux Corp. , Mountain View, Calif. Business: Drug delivery Appointed: Jim Barrett, general partner at New Enterprise Associates; Mike Raab, a partner at New Enterprise; Justin Duckworth, investment advisor at HBM Partners AG; and Nomura Phase4...
...technology into Macroflux Corp. (Mountain View, Calif.). Alza will retain an undisclosed stake in the newco. Macroflux... ...to enter Phase II testing to treat severe osteoporosis by the first half of 2007. Macroflux... ...COO of Pharmion Corp , is Macroflux’s CEO. Peter Daddona, who was CSO of Alza’s Macroflux...
...Macroflux (Mountain View, Calif.). The newco will develop compounds using its Macroflux transdermal delivery technology. Macroflux... ...The product is expected to enter Phase II testing by the first half of 2007. Macroflux... ...Pharmion (PHRM), is CEO of the newco; and Peter Daddona, who was CSO of Alza's Macroflux...
